Secondary Endpoints of a Phase II Randomized Trial (RTOG 0212): Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients with Limited Disease Small-cell Lung Cancer

Journal article

A Wolfson, K Bae, R Komaki, C Meyers, B Movsas, C Le Pechoux, M Werner-Wasik, G Videtic, Y Garces and H Choy

International journal of radiation oncology, biology, physics, Vol.75(3), pp.S34-S34

2009

Metrics

3 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.199 Lung Cancer; 1.199.1885 Small Cell Lung Cancer
Web Of Science research areas: Oncology; Radiology, Nuclear Medicine & Medical Imaging
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Secondary Endpoints of a Phase II Randomized Trial (RTOG 0212): Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients with Limited Disease Small-cell Lung Cancer
Creators: A Wolfson - University of Miami
K Bae - RTOG Foundation
R Komaki - The University of Texas MD Anderson Cancer Center
C Meyers - The University of Texas MD Anderson Cancer Center
B Movsas - Henry Ford Health System
C Le Pechoux - Institut Gustave Roussy
M Werner-Wasik - Jefferson College
G Videtic - Cleveland Clinic
Y Garces - Mayo Clinic
H Choy - The University of Texas Southwestern Medical Center
Publication Details: International journal of radiation oncology, biology, physics, Vol.75(3), pp.S34-S34
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031713545202976